Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Thursday, April 24, 2014
 Services
Submit a manuscript
Subscribe
Individuals
Institutions
Response
Send response
Read responses
Reprint
Advance online publication
Sign up for e-alert
JCIM job opportunities
Contact JCIM
 Information For
Readers
Authors
Reviewers
Advertisers
 About JCIM
Journal description
Editorial policy
Privacy policy
Copy right
Editorial staff
 Language Polishing
Journal of Chinese Integrative Medicine: 2012; 10(4): 390-397
DOI: 10.3736/jcim20120407
Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial
1. Ying-chun Miao (Department of Geriatrics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China )
2. Jin-zhou Tian (Department of Geriatrics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China E-mail: E-mail: jztian@hotmail.com)
3. Jing Shi (Department of Geriatrics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China )
4. Min Mao (Department of Clinical Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China )
BACKGROUND: It is important to detect and prevent Alzheimer disease (AD) at its early stage. Constituting the early stage sign of AD, amnestic mild cognitive impairment (aMCI) has drawn much attention. Studies have shown that donepezil could reduce the AD assessment scale-cognitive subscale (ADAS-Cog) score in MCI patients and improve the patient’s attention and speed of response; however, it also has many side effects. Therefore, the authors aim to explore the effects of Chinese herbal medicine for treating aMCI.
OBJECTIVE: To explore the clinical efficacy and safety of Chinese medicine for tonifying the kidney, and resolving phlegm and blood stasis in the treatment of aMCI.
DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: This clinical trial used randomized, double-blind, double-dummy and parallel-controlled design. According to the randomized, double-blind principle, some aMCI patients were randomly divided into Chinese medicine group and donepezil group. Other patients who did not receive any treatment were enrolled as the control. Patients in the Chinese medicine group received oral administration of Chinese medicine, 1 bag/dose, two doses per day, while patients in the donepezil group received donepezil hydrochloride, 5 mg/day. Twelve weeks were allocated as the trial period.
MAIN OUTCOME MEASURES: After 12 weeks, the Chinese medicine group patients, the donepezil group patients and those patients who did not receive any treatment were accessed using the scores of ADAS-Cog and mini-mental status examination (MMSE).
RESULTS: The ADAS-Cog and MMSE scores of the Chinese medicine group and the donepezil group were both improved from baseline (P=0.001, P=0.000), but the non-treatment group showed no change from baseline (P=0.151, P=0.125); furthermore, there was no significant difference between the Chinese medicine group and the donepezil group. The attention function of the Chinese medicine group was better than baseline (P=0.015), but no change was seen in the donepezil group (P=0.085) at the 12th week. Safety data showed that the occurrence of insomnia, nausea and diarrhea was greater in the donepezil group than in the Chinese medicine group (P=0.002, P=0.005, P=0.000), and both treatments had no influence in participants’ vital signs and laboratory examination results.
CONCLUSION: Both Chinese medicine and donepezil can improve global cognition in patients with aMCI after 12 weeks of treatment. Chinese medicine can also improve attention function and some clinical symptoms in patients with aMCI. Furthermore, Chinese medicine is safe for aMCI patients. Further study is necessary to explore the long-term effect of Chinese medicine for aMCI.
Welcome to JCIM! You are the number 3119 reader of this article!
Download Article:
[Full Text]      [PDF]      [Chinese]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Miao YC, Tian JZ, Shi J, Mao M. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2012; 10(4): 390-397.
References:
1Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia[J].BMJ, 1978, 2(6150): 1457-1459.  .
2Perry EK. The cholinergic hypothesis — ten years on[J].Br Med Bull, 1986, 42(1): 63-69.  .
3Giacobini E. From molecular structure to Alzheimer therapy[J].Jpn J Pharmacol, 1997, 74(3): 225-241.  .
4Giacobini E. Invited review: Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications[J].Neurochem Int, 1998, 32(5-6): 413-419.  .
5Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Mller HJ, Rogers SL, Friedhoff LT. The effects of donepezil in Alzheimer’s disease — results from a multinational trial[J].Dement Geriatr Cogn Discord, 1999, 10(3): 237-244.  .
6Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease. Donepezil Study Group[J].Neurology, 1998, 50(1): 136-145.  .
7Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group[J].Neurology, 2000, 54(12): 2269-2276.  .
8Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S; Donepezil 401 Study Group. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004; 63(4): 651-657.
9Tian JZ, Song CS, Ren Y, Liu XH, Yuan ZX. Effects of compound rhubarb preparation on memory of mice with D-galactose-induced subacute senility[J].Zhongguo Lao Nian Xue Za Zhi, 1996, 16(1): 39-40. Chinese.
10Li H, Liu F, Xu LR, Hou LF, Cui L, Luo ZG. Effect of Huannao Yicong Capsule on senile mild cognitive impairment[J].Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004, 24(8): 689-693. Chinese with abstract in English.
11Tian JZ, Shi J, Zhang XQ, Bi Q, Ma X, Wang ZL, Li XB, Sheng SL, Li L, Wu ZY, Fang LY, Zhao XD, Miao YC, Wang PW, Ren Y, Yin JX, Wang YY. Guiding principles of clinical research on mild cognitive impairment (protocol)[J]. J Chin Integr Med, 2008, 6(1): 9-14. Chinese with abstract in English.
12Tian JZ, Shi J, Zhang XQ, Bi Q, Ma X, Wang ZL, Li XB, Sheng SL, Li L, Wu ZY, Fang LY, Zhao XD, Miao YC, Wang PW, Ren Y, Yin JX, Wang YY. An explanation on “guiding principles of clinical research on mild cognitive impairment (protocol)”[J]. J Chin Integr Med, 2008, 6(1): 15-21. Chinese.
13Miao YC, Tian JZ, Shi J, Mao M, Zhao XD, Fang LY, Long ZY, Sun WJ, Lu HM, Wang ZL, Li XB. Characteristics of TCM syndromes of amnestic mild cognitive impairment[J].Zhong Yi Za Zhi, 2009, 50(3): 244-247. Chinese with abstract in English.
14Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer’s Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment[J].N Engl J Med, 2005, 352(23): 2379-2388.  .
15Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician[J].J Psychiatr Res, 1975, 12(3): 189-198.  .
16Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease[J].Am J Psychiatry, 1984, 141(11): 1356-1364.  .
17Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living[J].Gerontologist, 1969, 9(3): 179-186.  .
18Mohs RC, Cohen L. Alzheimer’s Disease Assessment Scale (ADAS)[J].Psychopharmacol Bull, 1988, 24(4): 627-628.  .
19Mobs RC, Rosen WG. The Alzheimer’s disease assessment scale: an instrument for assessing treatment efficacy[J].Psychopharmacol Bull, 1983, 19(3): 448-450.  .

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977